ALLE
53
-2
PDCO
46
-6
NDAQ
49
5
CMI
71
2
VFC
22
-4
MUR
47
-3
TROW
58
2
CME
52
-7
O
44
4
NI
58
-4
GWW
60
2
ROK
50
10
RHI
33
3
GIS
63
2
V
74
2
CI
66
-3
GE
68
-2
AKAM
40
-16
SWK
64
2
CL
69
2
ALLE
53
-2
PDCO
46
-6
NDAQ
49
5
CMI
71
2
VFC
22
-4
MUR
47
-3
TROW
58
2
CME
52
-7
O
44
4
NI
58
-4
GWW
60
2
ROK
50
10
RHI
33
3
GIS
63
2
V
74
2
CI
66
-3
GE
68
-2
AKAM
40
-16
SWK
64
2
CL
69
2
Financhill
Back

Arcturus Therapeutics Holdings Vs. Protalix BioTherapeutics Industry Stock Comparison

Sell
47

ARCT
Arcturus Therapeutics Holdings

Last Price:
27.21
Seasonality Move:
27.82%
Buy
56

PLX
Protalix BioTherapeutics

Last Price:
1.11
Seasonality Move:
0.94%
Sell
47
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $27.26. The Score for ARCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Protalix BioTherapeutics (PLX) is a Buy

Is Protalix BioTherapeutics a Buy, Sell or Hold?

  • The current Protalix BioTherapeutics [PLX] share price is $1.10. The Score for PLX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • PLX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $27.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight buying pressure.

PLX Stock Price Chart

What is Protalix BioTherapeutics's stock price today?

  • The Protalix BioTherapeutics share price today is $1.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing slight buying pressure.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.19 Sell
Relative Strength Index (14 RSI): 43.99 Sell
Chaikin Money Flow: 148078 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.09 - 30.05) Sell
Bollinger Bands (100): (29.07 - 37.11) Sell

PLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 42.27 Sell
Chaikin Money Flow: 582281 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.12 - 1.24) Sell
Bollinger Bands (100): (1.22 - 1.64) Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.23 Buy
20-day SMA: 27.21 Buy
50-day SMA: 31.53 Sell
200-day SMA: 29.52 Sell
8-day EMA: 27.14 Buy
20-day EMA: 27.89 Sell
50-day EMA: 30.18 Sell
200-day EMA: 29.67 Sell

PLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.16 Sell
20-day SMA: 1.16 Sell
50-day SMA: 1.27 Sell
200-day SMA: 1.54 Sell
8-day EMA: 1.16 Sell
20-day EMA: 1.18 Sell
50-day EMA: 1.26 Sell
200-day EMA: 1.49 Sell

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.93 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.79 per share, and an increase next year of $2.08 per share.

Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protalix BioTherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):